CNX-774
Selleck Chemicals
SKU:S7257-10MG
Couldn't load pickup availability
CNX-774 is an inhibitor of BTK used in studies of Immune Signaling. In practice, this places the compound in experiments that measure cytokine-mediated signaling and inflammatory effector responses in angiogenesis, cancer, and cell signaling models.
By inhibiting BTK, CNX-774 can be used to examine cytokine-mediated signaling and inflammatory effector responses. The kinase annotation adds relevance to biochemical kinase assays, phospho-signaling studies, and selectivity profiling, together with downstream-response mapping in the same experimental setting. In angiogenesis, cancer, and cell signaling models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Target-focused assays involving BTK
- Pathway perturbation studies connected to Immune Signaling
- Concentration-response inhibition and target-dependence studies
- Biochemical kinase assays, phospho-signaling studies, and selectivity profiling
Overall, CNX-774 is appropriate when a defined chemical perturbant is needed to connect BTK with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in angiogenesis, cancer, and cell signaling models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Targets:
- BTK
- Target Class:
- Kinase
- Pathways:
- Immune Signaling
- Research Area:
- Angiogenesis • Cancer • Cell Signaling • Immunology
- CAS No.:
- 1202759-32-7
- Molecular Weight:
- 499.5
- Formula:
- C₂₆H₂₂FN₇O₃
- SMILES:
- CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC3=NC=C(C(=N3)NC4=CC(=CC=C4)NC(=O)C=C)F
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.